BEGRX
Price
$20.50
Change
+$0.10 (+0.49%)
Updated
Aug 4 closing price
Net Assets
3.65B
DGEFX
Price
$15.35
Change
+$0.09 (+0.59%)
Updated
Aug 4 closing price
Net Assets
512.14M
Interact to see
Advertisement

BEGRX vs DGEFX

BEGRX vs DGEFX Comparison Chart in %
View a ticker or compare two or three
VS
BEGRX vs. DGEFX commentary
Aug 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEGRX is a Hold and DGEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BEGRX has more cash in the bank: 3.65B vs. DGEFX (512M). DGEFX pays higher dividends than BEGRX: DGEFX (1.81) vs BEGRX (1.26). BEGRX was incepted earlier than DGEFX: BEGRX (64 years) vs DGEFX (9 years). DGEFX (1.10) is less costly to investors than BEGRX (0.76). DGEFX is a more actively managed with annual turnover of: 62.00 vs. BEGRX (46.86). DGEFX has a lower initial minimum investment than BEGRX: DGEFX (0) vs BEGRX (100000). BEGRX annual gain was more profitable for investors over the last year : 16.31 vs. DGEFX (14.11). DGEFX return over 5 years is better than : 54.25 vs. BEGRX (13.55).
BEGRXDGEFXBEGRX / DGEFX
Total Expense Ratio0.760.9878%
Annual Report Gross Expense Ratio0.761.1069%
Fund Existence64 years9 years-
Gain YTD9.67713.19073%
Front LoadN/AN/A-
Min. Initial Investment1000000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.65B512M713%
Annual Yield % from dividends1.261.8170%
Returns for 1 year16.3114.11116%
Returns for 3 years36.3548.0676%
Returns for 5 years13.5554.2525%
Returns for 10 years44.33N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTGN0.300.06
+22.45%
VistaGen Therapeutics
DYN25.970.73
+2.89%
Dyne Therapeutics
GSBD8.950.13
+1.47%
Goldman Sachs BDC
AMP553.581.51
+0.27%
Ameriprise Financial
LFAC10.010.02
+0.20%
Leapfrog Acquisition Corp.